Cresco Labs to Report Fourth Quarter and Annual 2023 Financial Results on March 13, 2024
Cresco Labs Inc. announces the reporting of financial results for Q4 and year-end 2023, along with a conference call and webcast to discuss business highlights.
02/27/2024 - 07:30 AM
CHICAGO --(BUSINESS WIRE)--
Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the fourth quarter and year ended December 31st , 2023 on Wednesday, March 13th , 2024 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Event : Cresco Labs Fourth Quarter 2023 Earnings Conference Call
Date : Wednesday, March 13th , 2024
Time : 8:30 am EST
Webcast: LINK
Dial-in : 1-833-470-1428 (US Toll Free), 1-404-975-4839 (US Local)
Access Code : 614771
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website .
About Cresco Labs Inc.
Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs’ journey by visiting www.crescolabs.com or following the Company on Facebook , X or LinkedIn .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240227005055/en/
Media
Jason Erkes, Chief Communications Officer
press@crescolabs.com
312-953-2767
Investors
investors@crescolabs.com
General Inquiries
312-929-0993
info@crescolabs.com
Source: Cresco Labs
When will Cresco Labs report financial results for Q4 and year-end 2023?
Cresco Labs will report financial results for Q4 and year-end 2023 on Wednesday, March 13th, 2024.
What time will the conference call discussing financial results take place?
The conference call discussing financial results will take place at 8:30 am EST on Wednesday, March 13th, 2024.
Where can investors access the webcast of the conference call?
Investors can access the webcast of the conference call on the Cresco Labs investor relations website.
CRLBF Rankings
N/A Ranked by Stock Gains
CRLBF Stock Data
Industry
Medicinal and Botanical Manufacturing
Sector
Manufacturing
Tags
Pharmaceuticals: Other, Health Technology, Process Industries, Agricultural Commodities/Milling
Country
US
City
Chicago
About CRLBF
cresco labs llc is an illinois medical cannabis company, licensed to develop and operate medical cannabis cultivation centers in police districts 5, 9 and 21, according to illinois’ office of the governor. cresco labs exceeded the state’s rigorous qualifying standards, receiving the highest scores of any cultivation center applicant to obtain three of 18 total awarded cultivation licenses as part of the illinois medical cannabis pilot program.